Related Experiment Video
Updated: Nov 10, 2025

Engineering Antiviral Agents via Surface Plasmon Resonance
Published on: June 14, 2022
Computational epitope map of SARS-CoV-2 spike protein
Mateusz Sikora1,2, Sören von Bülow1, Florian E C Blanc1
1Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.
Researchers mapped the SARS-CoV-2 spike protein's antibody binding sites using molecular dynamics simulations. This reveals new targets for vaccine design by analyzing the dynamic, glycosylated surface of the spike protein.
Area of Science:
- Structural biology
- Immunology
- Computational biophysics
Background:
- The SARS-CoV-2 spike (S) protein is the primary target for COVID-19 vaccines, mediating viral entry into host cells.
- Understanding antibody binding sites on the S protein is crucial for developing effective vaccines.
Purpose of the Study:
- To identify potential antibody binding sites (epitopes) on the SARS-CoV-2 spike protein.
- To explore the role of protein dynamics and glycosylation in epitope accessibility.
- To provide candidates for structure-based vaccine design.
Main Methods:
- Conducted multi-microsecond molecular dynamics simulations of a large system containing four full-length, glycosylated, and palmitoylated SARS-CoV-2 S proteins.
- Analyzed steric accessibility, structural rigidity, sequence conservation, and antibody binding signatures to map epitopes.
- Evaluated the impact of the dynamic glycan coat on epitope exposure.
Main Results:
- Successfully identified known epitopes on the S protein and discovered novel potential epitope candidates.
- Demonstrated that the extensive and flexible glycan coat significantly shields larger surface areas than static structures suggest.
- Observed that the glycan shield and hinge flexibility result in low epitope scores for the S protein stalk.
Conclusions:
- The study highlights the critical importance of considering protein dynamics and glycosylation in epitope mapping.
- The computational epitope-mapping approach is generalizable and applicable to other viral envelope proteins.
- Findings offer valuable insights for designing next-generation, structure-based vaccines against SARS-CoV-2 and other viruses.
More Related Videos
08:07Author Spotlight: Advancing Antiviral Strategies Through Novel Immunocapture and Mass Spectrometry Techniques
Published on: January 12, 2024
06:39High-throughput Confocal Imaging of Quantum Dot-Conjugated SARS-CoV-2 Spike Trimers to Track Binding and Endocytosis in HEK293T Cells
Published on: April 21, 2022